These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12073379)

  • 1. Amgen warns of fake Epogen vials in U.S.
    Nephrol News Issues; 2002 Jun; 16(7):10. PubMed ID: 12073379
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA warns about counterfeit Epogen.
    AIDS Alert; 2002 Aug; 17(8):102-3. PubMed ID: 12647693
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA warns about counterfeit drug.
    AIDS Patient Care STDS; 2003 May; 17(5):258. PubMed ID: 12825589
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of illegal trade on the quality of epoetin alfa in Thailand.
    Fotiou F; Aravind S; Wang PP; Nerapusee O
    Clin Ther; 2009 Feb; 31(2):336-46. PubMed ID: 19302906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical assessment of erythropoietin products from Asia versus US Epoetin alfa manufactured by Amgen.
    Park SS; Park J; Ko J; Chen L; Meriage D; Crouse-Zeineddini J; Wong W; Kerwin BA
    J Pharm Sci; 2009 May; 98(5):1688-99. PubMed ID: 18781649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
    Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incentives to promote the US pharmaceutical innovation: empirical research based on the case of Epogen.
    Zhang L; Wang J
    Drug Dev Ind Pharm; 2021 May; 47(5):820-824. PubMed ID: 34056986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warning, counterfeit Procrit (epoetin alfa).
    AIDS Treat News; 2003 Mar; (389):8. PubMed ID: 12712940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis facility ownership and epoetin dosing in hemodialysis patients: a US physician perspective.
    Kasiske BL
    Am J Kidney Dis; 2007 Sep; 50(3):354-7. PubMed ID: 17720512
    [No Abstract]   [Full Text] [Related]  

  • 10. Translating epoetin research into practice: the role of government and the use of scientific evidence.
    Lazarus JM; Hakim RM
    Nephrol News Issues; 2006 Dec; 20(13):12, 22. PubMed ID: 17168053
    [No Abstract]   [Full Text] [Related]  

  • 11. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
    Hayslip D
    Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.
    Steensma DP; Molina R; Sloan JA; Nikcevich DA; Schaefer PL; Rowland KM; Dentchev T; Novotny PJ; Tschetter LK; Alberts SR; Hogan TF; Law A; Loprinzi CL
    J Clin Oncol; 2006 Mar; 24(7):1079-89. PubMed ID: 16505427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information from your family doctor. Avoiding counterfeit drugs.
    American Academy of Family Physicians
    Fam Pract Manag; 2007 Mar; 14(3):36. PubMed ID: 17408129
    [No Abstract]   [Full Text] [Related]  

  • 14. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
    Henry DH; Bowers P; Romano MT; Provenzano R
    Arch Intern Med; 2004 Feb; 164(3):262-76. PubMed ID: 14769622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counterfit drugs: check Combivir, Serostim, Epogen.
    James JS
    AIDS Treat News; 2002 May; (380):3-4. PubMed ID: 12085844
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
    Leyland-Jones B; Semiglazov V; Pawlicki M; Pienkowski T; Tjulandin S; Manikhas G; Makhson A; Roth A; Dodwell D; Baselga J; Biakhov M; Valuckas K; Voznyi E; Liu X; Vercammen E
    J Clin Oncol; 2005 Sep; 23(25):5960-72. PubMed ID: 16087945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
    Chang J; Couture F; Young S; McWatters KL; Lau CY
    J Clin Oncol; 2005 Apr; 23(12):2597-605. PubMed ID: 15452188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA notifications. Watch out for counterfeit Procrit, 2 lot numbers.
    AIDS Alert; 2002 Aug; 17(8):101-2. PubMed ID: 12647690
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
    Schouwink JH; Codrington H; Sleeboom HP; Kerkhofs LG; Wormhoudt LW
    Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.